Jubilant DraxImage Inc. (JDI), a Jubilant Life Sciences Company, has executed a Letter of Intent with Positron Corp., under which Positron will supply API-grade Sr-82 for the JDI Sr-82/Rb-82 generator; both companies will co-promote JDI Sr-82/Rb-82 generators to end-users upon FDA clearance; and Positron will provide lifecycle management for expired JDI Sr-82/Rb-82 generators.
 
Positron will secure a generator supply for future sales of cardiac PET scanners and JDI will secure a reliable supply of Sr-82, a vendor for expired generators management, and a strategic partner with a customer base of cardiac PET scanners installed and serviced.
 
Martyn Coombs, president of JDI, said, “Through its wholly owned subsidiary, Manhattan Isotope Technology (MIT), Positron positioned itself as the only private entity in the U.S. with the practical experience of servicing the Sr82/Rb82 generator lifecycle. Their ability to provide a more stable and secure supply of API Sr-82 and management of expired Sr-82/Rb-82 generators fits well with JDI’s pre-launch strategy. “
 
Patrick Rooney, chief executive officer of Positron, said, “JDI has developed a robust Sr82/Rb82 generator and elution system. As the Sr82/Rb82 generator on the market has enjoyed tremendous growth and the merits of the technology have been validated many times over, we strongly believe that the arrival of an alternative, upon the FDA clearance of JDI’s generator, will be welcomed by the cardiac PET community.”